Tumor-induced Osteomalacia Disease Monitoring Program

计划入组 23 人 · 首次发布于 2021 年 3 月 5 日

BGJ398 for the Treatment of Tumor-Induced Osteomalacia

计划入组 4 人 · 首次发布于 2018 年 4 月 27 日

Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia

计划入组 45 人 · 首次发布于 2004 年 12 月 20 日

Autologous Tumor Lysate-pulsed Dendritic and Cytokine-induced Killer Cells

Tumor ncoantigen

induced pluripotent stem cells

Stiftung Swiss Tumor Institute

Switzerland

National Center for Tumor Diseases

Germany

The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital)

China

B Cell Abnormalities Predict Treatment Response in Triple-Negative Breast Cancer

Burosumab Shows Dramatic Mobility Gains in Children with Severe Fibrous Dysplasia

Ersodetug Receives FDA Orphan Drug Designation for Tumor-Induced Hypoglycemia